|
Volumn 425, Issue 1, 2000, Pages 121-129
|
Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients
|
Author keywords
Basal ganglia; Dopaminergic areas; Primates; Tracing methods
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
FLUOROGOLD;
TYROSINE 3 MONOOXYGENASE;
ADULT;
AGED;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BASAL GANGLION;
CELL LABELING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DOPAMINERGIC NERVE CELL;
DOPAMINERGIC SYSTEM;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
MONKEY;
NONHUMAN;
PARKINSON DISEASE;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
QUANTITATIVE ASSAY;
SUBTHALAMIC NUCLEUS;
AGED;
AGED, 80 AND OVER;
ANIMAL;
AXONS;
BASAL GANGLIA;
BIOTIN;
CERCOPITHECUS AETHIOPS;
COMPARATIVE STUDY;
DEXTRANS;
DOPAMINE;
FLUORESCENT DYES;
HUMAN;
MALE;
MIDDLE AGE;
MPTP POISONING;
NEURAL PATHWAYS;
NEURONS;
PARKINSON DISEASE;
SUBTHALAMIC NUCLEUS;
SUPPORT, NON-U.S. GOV'T;
TYROSINE 3-MONOOXYGENASE;
|
EID: 0034638249
PISSN: 00219967
EISSN: None
Source Type: Journal
DOI: 10.1002/1096-9861(20000911)425:1<121::AID-CNE10>3.0.CO;2-G Document Type: Article |
Times cited : (95)
|
References (33)
|